| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.37 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.29 | 0.3 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.22 | 3e-05 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.21 | 0.5 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.21 | 0.5 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.19 | 9e-05 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0005 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |